Table 3 Details about treatments for active bleeding.
EMR, endoscopic mucosal resection; ERCP, endoscopic retrograde cholangiopancreatography; ESD, endoscopic submucosal dissection; PEG, percutaneous endoscopic gastrostomy; WOPN, walled-off pancreatic necrosis. | |
Number of patients | 91 |
PuraStat as primary modality | 30 (33) |
Other primary treatment modality + PuraStat as secondary modality | 61 (67) |
|
|
Cause of bleeding treated with PuraStat alone | Endoscopic intraprocedural 16
|
Ulcer 7
|
|
Angiodysplasia 2
|
|
Mallory-Weiss tear 1 Anastomotic bleeding 1 Duodenal mass lesion 1 Duodenal necrosis 1 Post PEG placement 1 |
|
Cause of bleeding treated with injection of a hemostatic agent + PuraStat | Endoscopic intraprocedural 7
|
Ulcer 8
|
|
Duodenal angiodysplasia 1 Radiation proctopathy 1 |
|
Cause of bleeding treated with thermal hemostasis + PuraStat | Endoscopic intraprocedural 2
|
Angiodysplasia 3
|
|
Duodenal mass lesion 1 | |
Cause of bleeding treated with mechanical hemostasis + PuraStat | Endoscopic intraprocedural 5
|
Ulcer 4
|
|
Angiodysplasia 3
|
|
Anastomotic bleeding 3 Diverticular bleeding 1 |
|
Cause of bleeding treated with combination modality + PuraStat | Endoscopic intraprocedural 9
|
Ulcer 9
|
|
Angiodysplasia 2
|
|
Gastric mass lesion 1 Anastomotic bleeding 1 |
|
Cases of rebleeding within 30 days | After PuraStat as primary treatment 3
|
After mechanical hemostasis + PuraStat 1
|
|
After injective hemostasis + PuraStat 1
|
|
After combination modality + PuraStat 2
|